The American biotechnology company AnaptysBio Inc has announced that the court has ruled to uphold the existing royalty rate arrangement between the two parties and has officially rejected Tesaro's request to reduce the royalty rate.

The American biotechnology company AnaptysBio Inc has announced that the court has ruled to uphold the existing royalty rate arrangement between the two parties and has officially rejected Tesaro's request to reduce the royalty rate.

老虎证券2026/04/24 19:51

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This ruling confirms that AnaptysBio's rights under the relevant cooperation agreement remain unaffected, and the current fee rate will continue to apply. The decision ends the legal dispute between the two parties regarding royalty issues, providing certainty for the company's future revenue expectations.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The American biotechnology company AnaptysBio Inc has announced that the court has ruled to uphold the existing royalty rate arrangement between the two parties and has officially rejected Tesaro's request to reduce the royalty rate.

You may also like

Crypto prices